These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 17936676)
1. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Kaomongkolgit R; Cheepsunthorn P; Pavasant P; Sanchavanakit N Oral Oncol; 2008 Jun; 44(6):587-94. PubMed ID: 17936676 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134 [TBL] [Abstract][Full Text] [Related]
3. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016 [TBL] [Abstract][Full Text] [Related]
4. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224 [TBL] [Abstract][Full Text] [Related]
5. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3. Horváth B; Hegyesi H; Nagy P; Falus A; Schaff Z Head Neck; 2005 Jul; 27(7):585-96. PubMed ID: 15887216 [TBL] [Abstract][Full Text] [Related]
6. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745 [TBL] [Abstract][Full Text] [Related]
7. In vitro enhancement effect of humic acid on the progression of lung cancer cells. Lee WJ; Lu FJ; Wang SF; Chen YR; Tseng TH Chem Biol Interact; 2009 Oct; 181(3):463-71. PubMed ID: 19686714 [TBL] [Abstract][Full Text] [Related]
8. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Samara GJ; Lawrence DM; Chiarelli CJ; Valentino MD; Lyubsky S; Zucker S; Vaday GG Cancer Lett; 2004 Oct; 214(2):231-41. PubMed ID: 15363550 [TBL] [Abstract][Full Text] [Related]
9. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493 [TBL] [Abstract][Full Text] [Related]
10. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole. Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. O-Charoenrat P; Rhys-Evans PH; Eccles SA Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356 [TBL] [Abstract][Full Text] [Related]
13. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502 [TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Hou CH; Hsiao YC; Fong YC; Tang CH Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372 [TBL] [Abstract][Full Text] [Related]
15. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. Behren A; Simon C; Schwab RM; Loetzsch E; Brodbeck S; Huber E; Stubenrauch F; Zenner HP; Iftner T Cancer Res; 2005 Dec; 65(24):11613-21. PubMed ID: 16357172 [TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes. Wang HH; Hsieh HL; Wu CY; Sun CC; Yang CM Glia; 2009 Jan; 57(1):24-38. PubMed ID: 18661553 [TBL] [Abstract][Full Text] [Related]
17. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Cho HJ; Kang JH; Kwak JY; Lee TS; Lee IS; Park NG; Nakajima H; Magae J; Chang YC Carcinogenesis; 2007 May; 28(5):1104-10. PubMed ID: 17114644 [TBL] [Abstract][Full Text] [Related]
19. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732 [TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]